Singapore markets closed

Straits Times Index
3,292.69
+10.64(+0.32%)
Nikkei
38,405.66
+470.90(+1.24%)
Hang Seng
17,763.03
+16.12(+0.09%)
FTSE 100
8,144.13
-2.90(-0.04%)
Bitcoin USD
59,844.25
-3,137.73(-4.98%)
CMC Crypto 200
1,277.36
-61.70(-4.61%)

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

13.94

-0.24

(-1.69%)

At close: 04:00PM EDT

13.94

0.00

(0.00%)

After hours:

04:20PM EDT

Trade prices are not sourced from all markets

News

Insider Monkey
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript April 25, 2024 Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.8 EPS, expectations were $-1.63. Sage Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
Simply Wall St.
Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates
Investors in Sage Therapeutics, Inc. ( NASDAQ:SAGE ) had a good week, as its shares rose 2.7% to close at US$13.69...
Zacks
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.